Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ARTH

Arch Therapeutics

$0.00

(0.00%)

, IMXI

International Money Express

$10.47

(0.00%)

10:21
09/12/18
09/12
10:21
09/12/18
10:21
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

ARTH

Arch Therapeutics

$0.00

(0.00%)

IMXI

International Money Express

$10.47

(0.00%)

ICPT

Intercept

$116.25

2.47 (2.17%)

HII

Huntington Ingalls

$246.84

3.22 (1.32%)

ZGNX

Zogenix

$48.00

-0.35 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 17

    Sep

  • 22

    Oct

ARTH

Arch Therapeutics

$0.00

(0.00%)

07:12
09/12/18
09/12
07:12
09/12/18
07:12
Initiation
Arch Therapeutics initiated at Ladenburg »

Arch Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ARTH

Arch Therapeutics

$0.31

-0.0165 (-5.12%)

08:04
03/14/18
03/14
08:04
03/14/18
08:04
Downgrade
Arch Therapeutics rating change at IFS Securities »

Arch Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARTH

Arch Therapeutics

$0.78

-0.00647 (-0.82%)

04:55
10/12/17
10/12
04:55
10/12/17
04:55
Conference/Events
Arch Therapeutics management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

ARTH

Arch Therapeutics

$0.78

-0.011 (-1.39%)

09:48
10/10/17
10/10
09:48
10/10/17
09:48
Conference/Events
Arch Therapeutics management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.